Corazon (Corsee) D. Sanders Bei Gene, Ltd. (BGNE) insider trading activity

Corazon (Corsee) D. Sanders is Director of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Sep 05, 2025, when has been sold 2,665 shares (American Depositary Shares) at a price of $337.0 per share, resulting in proceeds of $898,105. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Corazon (Corsee) D. Sanders Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 05 2025	SELL Open market or private sale	$898,105 $337.0 p/Share	2,665 Reduced 100.0%	0 American Depositary Sh...
Sep 05 2025	BUY Exercise of conversion of derivative security	$414,887 $155.68 p/Share	2,665 Added 50.0%	2,665 American Depositary Sh...
May 21 2025	BUY Grant, award, or other acquisition	-	10,985 Added 16.1%	57,226 Ordinary Shares
Jun 05 2024	BUY Grant, award, or other acquisition	-	16,341 Added 26.11%	46,241 Ordinary Shares
Jun 23 2023	SELL Open market or private sale	$105,022 $181.7 p/Share	578 Reduced 100.0%	0 American Depositary Sh...
Jun 15 2023	BUY Grant, award, or other acquisition	-	12,922 Added 25.67%	37,414 Ordinary Shares
Jun 22 2022	BUY Grant, award, or other acquisition	-	16,692 Added 40.53%	24,492 Ordinary Shares
Jun 16 2021	BUY Grant, award, or other acquisition	-	7,800 Added 50.0%	7,800 Ordinary Shares

Also insider at

MTEM

Molecular Templates, Inc. Healthcare

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

C(D